Zvast BiotechnologyZvast Biotechnology

Online
Email
Telephone
Tel: +86 199 7918 0822
WhatsApp
WhatsApp
Top
Disease Models

Disease Model

Location: Home Large Animal Model Beagle Beagle Mandibular Defect Model
Beagle Mandibular Defect Model
Application

Mandibular Defect

Modeling Method

Verifacition

Modeling Principle


The Beagle Mandibular Critical-Sized Bone Defect Model is a standardized SCI-recognized large-animal model in translational oral and maxillofacial medicine and bone tissue engineering. Surgically standardized critical-sized bone defects (CSD) are created in bilateral mandibular bodies. Such defects cannot achieve spontaneous osseous healing relying on endogenous regenerative capacity, and the defective region remains persistent bone loss, which facilitates quantitative evaluation of in vivo osteogenic efficacy of various bone grafts, biomaterial scaffolds, growth factors, stem cell composites and guided bone regeneration (GBR) strategies. The jaw anatomy, trabecular arrangement of alveolar bone, mandibular blood circulation, bone remodeling rate, periodontal soft-hard tissue complex structure and temporal profile of bone defect repair of Beagle dogs are highly homologous to human jaw bone. Compared with small rodents, Beagle dogs possess superior cortical bone thickness, medullary cavity volume and bone turnover rate, which faithfully recapitulate clinical scenarios including jaw bone defects, alveolar ridge atrophy and pre-implant bone augmentation. Bilateral symmetric defects enable intra-animal control design, effectively reducing experimental errors caused by individual variation. Defect dimension, surgical approach, hemostasis strategy and soft tissue closure protocol can be quantitatively standardized with low intra-group variation, and experimental reproducibility meets the criteria of high-impact stomatological SCI journals. This model is widely adopted for preclinical efficacy and biosafety evaluation of novel bone repair scaffolds, osteoinductive growth factors, resorbable barrier membranes, 3D-printed bone constructs, genetically modified stem cells, biomaterial degradation behavior and bone-material integration interface.


Modeling Success Criteria


Quantitative Imaging Criteria


Complete osseous closure cannot be observed in blank defect control group within designated observation period. Micro-CT quantification reveals low bone volume fraction (BV/TV), clear defect boundary and persistent bone defect cavity. Immediate postoperative CBCT confirms no significant deviation between actual defect dimension and preset standard. Imaging examinations at each time point demonstrate stable defect boundary without pathological bone resorption or extensive osteonecrosis. Fulfillment of above criteria confirms successful establishment of critical-sized bone defect model with stable space-maintaining capacity, enabling reliable discrimination of osteogenic capacity among experimental groups.


Histomorphometric Gold-Standard Indexes


Fibrous connective tissue dominates inside defects of blank control group, newly formed bone is restricted to defect margin without continuous bone bridging in central region. Histomorphometric parameters: bone volume fraction (BV/TV) and trabecular number (Tb.N) are significantly lower than effective osteogenic treatment groups; trabecular separation (Tb.Sp) increases markedly. No extensive inflammatory infiltration or persistent chronic inflammation induced by foreign body giant cell aggregation is observed on histological sections (excluding surgical complications), indicating controllable surgical trauma and baseline inflammatory interference.


Academic Evidence for Critical-Sized Defect Validation


A critical-sized bone defect is defined as a bone defect that cannot achieve spontaneous osseous bridging relying on endogenous regenerative capacity within the observation period compatible with animal lifespan. The standardized penetrating cylindrical mandibular defect in this model meets biological characteristics of critical defect. Defect dimension exceeds the upper limit of natural endogenous repair, eliminating masking effect of autologous healing on experimental outcomes, and enables objective discrimination of osteogenic capacity among different biomaterials and active factors, which serves as core academic evidence verifying model reliability in bone regeneration research.


Model Advantages


Beagle mandibular critical-sized bone defect model represents the mainstream large-animal model in SCI publications focusing on dental implantation and bone tissue engineering. Bilateral intra-animal control design drastically reduces animal consumption and minimizes individual variation. Mandibular anatomy, bone metabolism and repair pattern are highly analogous to human alveolar bone, making it superior to rodent models for translational research. Intraoral surgical approach provides clear operative view without extraoral scarring and ensures satisfactory animal comfort. Standardized defect dimension enables stable establishment of critical defects to avoid interference from spontaneous healing. This model supports multiple intervention regimens including scaffold materials, cell therapy, growth factors and GBR membranes. Repeated in vivo CBCT follow-up is feasible, and Micro-CT, histological and molecular tests can be performed simultaneously at endpoint to form complete data chain. Relevant outputs are readily accepted by authoritative SCI journals in dentistry and maxillofacial surgery.

Research Applications


The Beagle Mandibular Critical-Sized Bone Defect Model is mainly applied to elucidate the complete regenerative cascade including local microenvironment of bone defects, clot organization, angiogenesis, mesenchymal cell recruitment, osteogenic differentiation and bone remodeling. It evaluates in vivo osteogenic capacity, biocompatibility, degradation kinetics and osseointegration of absorbable/non-absorbable bone repair scaffolds, stem cell composites, recombinant osteogenic growth factors, GBR barrier membranes and 3D-printed biomimetic bone materials. It explores regulatory effects of material modification strategies, gene delivery systems and local sustained drug release systems on bone regeneration. This model supports preclinical safety and efficacy verification of novel biomaterials for pre-implant alveolar ridge augmentation and bone defect reconstruction, acting as a core standardized large-animal model for translational researches in oral tissue engineering, maxillofacial bone repair and dental biomaterials.


Beagle mandibular critical-sized bone defect model, critical bone defect, alveolar bone regeneration, bone reconstruction, periodontal tissue engineering, translational stomatology preclinical model

Drop Us A Message

We're here to help! Whether you have questions about our products, need support, or want to share feedback, we'd love to hear from you. Please reach out through any of the methods below, and our team will get back to you as soon as possible.

Submit